800
Participants
Start Date
February 28, 2005
Primary Completion Date
March 31, 2007
Study Completion Date
March 31, 2008
17 alpha-Hydroxyprogesterone Caproate and Omega-3 supplement
Participants receive a weekly progesterone injection (17 alpha hydroxyprogesterone caproate) up to 37 weeks gestation and take daily Omega-3 supplements.
17 alpha-hydroxy progesterone caproate and Placebo supplement
Participants receive a weekly progesterone injection (17P) up to 37 weeks gestation and take daily placebo supplements
University of Alabama - Birmingham, Birmingham
Northwestern University, Chicago
Wayne State University, Detroit
Columbia University, New York
University of North Carolina - Chapel Hill, Chapel Hill
Wake Forest University School of Medicine, Winston-Salem
Case Western University, Cleveland
Ohio State University, Columbus
Drexel University, Philadelphia
University of Pittsburgh Magee Womens Hospital, Pittsburgh
Brown University, Providence
University of Utah Medical Center, Salt Lake City
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
The George Washington University Biostatistics Center
OTHER